Cigna Group $CI Stock Position Increased by Running Oak Capital LLC

Key Points

• Running Oak Capital LLC increased its stake in Cigna Group by 3.8% in Q2, holding 50,508 shares valued at approximately $16.7 million, making it the 26th largest position in its portfolio.
• Cigna Group reported a quarterly EPS of $7.20, beating analysts' estimates and showing an 11% increase in revenue year-over-year, signaling strong financial performance.
• Insider Nicole S. Jones sold over 28,500 shares on August 15th, marking a significant reduction in her holdings by 52.66% after the transaction.

Running Oak Capital LLC grew its position in Cigna Group (NYSE:CI - Free Report) by 3.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 50,508 shares of the health services provider's stock after purchasing an additional 1,859 shares during the period. Cigna Group makes up approximately 1.9% of Running Oak Capital LLC's holdings, making the stock its 26th biggest position. Running Oak Capital LLC's holdings in Cigna Group were worth $16,697,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. Flaharty Asset Management LLC bought a new stake in Cigna Group during the 1st quarter valued at $28,000. 1248 Management LLC acquired a new position in shares of Cigna Group during the first quarter valued at $29,000. Activest Wealth Management raised its stake in shares of Cigna Group by 360.0% during the first quarter. Activest Wealth Management now owns 92 shares of the health services provider's stock valued at $30,000 after purchasing an additional 72 shares in the last quarter. Retirement Wealth Solutions LLC lifted its holdings in Cigna Group by 74.1% in the second quarter. Retirement Wealth Solutions LLC now owns 101 shares of the health services provider's stock worth $33,000 after purchasing an additional 43 shares during the period. Finally, Saudi Central Bank bought a new position in Cigna Group in the 1st quarter valued at about $36,000. Institutional investors and hedge funds own 86.99% of the company's stock.

Insider Transactions at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 28,526 shares of the business's stock in a transaction dated Friday, August 15th. The stock was sold at an average price of $300.00, for a total transaction of $8,557,800.00. Following the sale, the insider owned 25,648 shares in the company, valued at approximately $7,694,400. The trade was a 52.66% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.70% of the company's stock.

Cigna Group Trading Up 4.8%

Cigna Group stock opened at $311.24 on Monday. The firm has a market cap of $83.08 billion, a price-to-earnings ratio of 16.99, a price-to-earnings-growth ratio of 0.91 and a beta of 0.45. Cigna Group has a 1 year low of $256.89 and a 1 year high of $358.88. The firm's 50 day moving average price is $292.41 and its two-hundred day moving average price is $309.65. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.71 and a current ratio of 0.71.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Thursday, July 31st. The health services provider reported $7.20 EPS for the quarter, beating analysts' consensus estimates of $7.15 by $0.05. The company had revenue of $67.13 billion during the quarter, compared to the consensus estimate of $62.61 billion. Cigna Group had a return on equity of 18.80% and a net margin of 1.92%.The company's quarterly revenue was up 11.0% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $6.72 EPS. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, research analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Thursday, September 18th. Investors of record on Thursday, September 4th were paid a $1.51 dividend. The ex-dividend date of this dividend was Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a yield of 1.9%. Cigna Group's dividend payout ratio (DPR) is currently 32.97%.

Wall Street Analyst Weigh In

A number of research firms have commented on CI. Guggenheim restated a "buy" rating and set a $350.00 price target (down from $388.00) on shares of Cigna Group in a research report on Monday, August 4th. Royal Bank Of Canada reiterated an "outperform" rating and set a $371.00 price objective on shares of Cigna Group in a research note on Thursday, June 26th. Weiss Ratings reissued a "hold (c+)" rating on shares of Cigna Group in a report on Saturday, September 27th. Barclays increased their price target on Cigna Group from $354.00 to $383.00 and gave the company an "overweight" rating in a research note on Thursday, September 4th. Finally, Wall Street Zen downgraded Cigna Group from a "buy" rating to a "hold" rating in a research note on Friday. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and three have given a Hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $371.81.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.